Sun Pharmaceutical Industries Limited has obtained Drugs Controller General of India (DCGI) approval to produce and sell a generic semaglutide injection. As a GLP-1 receptor agonist, the drug is approved for chronic weight management in adults when used alongside increased physical activity and a reduced-calorie diet. 

Sun Pharma will launch generic semaglutide injection under the brand name, Noveltreat, after the expiry of semaglutide patent in India. The product has received approval from the DCGI following a review of a Phase III clinical trial conducted in India. Noveltreat will be available in five dose strengths - 0.25 mg/0.5 mL, 0.5 mg/0.5 mL, 1 mg/0.5 mL, 1.7 mg/0.75 mL, and 2.4 mg/0.75 mL, with a maintenance dose of 2.4 mg once weekly. The product is administered via an easy-to-use prefilled pen, designed to support convenient and accurate dosing.  

“Obesity and diabetes have emerged as two of the most pressing health challenges confronting India and GLP-1 based therapies can play a meaningful role in addressing this growing burden. Noveltreat meets global quality standards and is supported by robust Indian clinical evidence on efficacy and safety for weight management. As India’s largest pharmaceutical company with leadership in cardiometabolic therapies, we are committed to improving access to generic semaglutide across the country after the patent expiry”, said Kirti Ganorkar, Managing Director, Sun Pharma.

“GLP-1 receptor agonists like semaglutide are an important scientific advancement for overall metabolic health, not just weight. These treatments should be combined with appropriate lifestyle measures such as diet and physical activity. They should be taken under close medical supervision. We are seeing growing patient interest in this therapy, and improved accessibility will help address unmet needs”, said Dr. Unnikrishnan A G, Chief Endocrinologist and CEO, Chellaram Diabetes Institute.

In December 2025, Sun Pharma received DCGI approval for manufacturing and marketing semaglutide injection for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise. It will be launched under the brand name Sematrinity, after the expiry of semaglutide patent in India.

Gandhar Oil Refinery India Ltd Q3FY26 consolidated profit slips QoQ to Rs. 32.39 crores
facebook sharing button Sharetwitter sharing button Tweetpinterest sharing button Pinsharethis sharing buttonwhatsapp sharing buttonemail sharing button
Posted On : 2026-01-23 22:30:51( TIMEZONE : IST )Gandhar Oil Refinery India Ltd Q3FY26 consolidated profit slips QoQ to Rs. 32.39 croresGandhar Oil Refinery India Limited has reported Consolidated financial results for the period ended December 31, 2025.
Financial Results (Q3 FY2026) - QoQ Comparison
The company has reported total income of Rs. 1170.64 crores during the period ended December 31, 2025 as compared to Rs. 1062.86 crores during the period ended September 30, 2025.
The company has posted net profit / (loss) of Rs. 32.39 crores for the period ended December 31, 2025 as against net profit / (loss) of Rs. 36.05 crores for the period ended September 30, 2025.


The company has reported EPS of Rs. 3.31 for the period ended December 31, 2025 as compared to Rs. 3.68 for the period ended September 30, 2025.

FinancialsQ3 FY2026Q2 FY2026% ChangeTotal Income₹ 1170.64 crs₹1062.86 crsUp Tick / Down Tick10.14%Net Profit₹32.39 crs₹36.05 crsUp Tick / Down Tick-10.15%EPS₹3.31₹3.68Up Tick / Down Tick-10.05%
Financial Results (Q3 FY2026) - YoY Comparison
The company has reported total income of Rs. 1170.64 crores during the period ended December 31, 2025 as compared to Rs.1007.43 crores during the period ended December 31, 2024.
The company has posted net profit / (loss) of Rs.32.39 crores for the period ended December 31, 2025 as against net profit / (loss) of Rs.19.33 crores for the period ended December 31, 2024.


The company has reported EPS of Rs.3.31 for the period ended December 31, 2025 as compared to Rs.1.98 for the period ended December 31, 2024.
FinancialsQ3 FY2026Q3 FY2025% ChangeTotal Income₹ 1170.64 crs₹1007.43 crsUp Tick / Down Tick16.20%Net Profit₹32.39 crs₹19.33 crsUp Tick / Down Tick67.56%EPS₹3.31₹1.98Up Tick / Down Tick67.17%
Financial Results (9 Months Ended FY2026) - YoY Comparison
The company has reported total income of Rs.3139.15 crores during the 9 Months period ended December 31, 2025 as compared to Rs.2944.66 crores during the 9 Months period ended December 31, 2024.


The company has posted net profit / (loss) of Rs.94.70 crores for the 9 Months period ended December 31, 2025 as against net profit / (loss) of Rs.68.37 crores for the 9 Months period ended December 31, 2024.xxxxxxxxxxxxxxxxxxxxxxx
Welspun Specialty Solutions Ltd Q3FY26 net profit at Rs. 9.51 crore
facebook sharing button Sharetwitter sharing button Tweetpinterest sharing button Pinsharethis sharing buttonwhatsapp sharing buttonemail sharing button
Posted On : 2026-01-23 22:29:15( TIMEZONE : IST )Welspun Specialty Solutions Ltd Q3FY26 net profit at Rs. 9.51 croreWelspun Specialty Solutions Ltd has reported Standalone financial results for the period ended December 31, 2025.
Financial Results (Q3 FY2026) - QoQ Comparison
The company has reported total income of Rs. 228.86 crores during the period ended December 31, 2025 as compared to Rs. 242.71 crores during the period ended September 30, 2025.
The company has posted net profit / (loss) of Rs. 9.51 crores for the period ended December 31, 2025 as against net profit / (loss) of Rs. 9.65 crores for the period ended September 30, 2025.


The company has reported EPS of Rs. 0.14 for the period ended December 31, 2025 as compared to Rs. 0.14 for the period ended September 30, 2025.

FinancialsQ3 FY2026Q2 FY2026% ChangeTotal Income₹ 228.86 crs₹242.71 crsUp Tick / Down Tick-5.71%Net Profit₹9.51 crs₹9.65 crsUp Tick / Down Tick-1.45%EPS₹0.14₹0.14Up Tick / Down Tick0.00%
Financial Results (Q3 FY2026) - YoY Comparison
The company has reported total income of Rs. 228.86 crores during the period ended December 31, 2025 as compared to Rs.199.57 crores during the period ended December 31, 2024.
The company has posted net profit / (loss) of Rs.9.51 crores for the period ended December 31, 2025 as against net profit / (loss) of Rs.-3.60 crores for the period ended December 31, 2024.


The company has reported EPS of Rs.0.14 for the period ended December 31, 2025 as compared to Rs.-0.07 for the period ended December 31, 2024.
FinancialsQ3 FY2026Q3 FY2025% ChangeTotal Income₹ 228.86 crs₹199.57 crsUp Tick / Down Tick14.68%Net Profit₹9.51 crs₹-3.60 crsUp Tick / Down Tick364.17%EPS₹0.14₹-0.07Up Tick / Down Tick300.00%
Financial Results (9 Months Ended FY2026) - YoY Comparison
The company has reported total income of Rs.682.59 crores during the 9 Months period ended December 31, 2025 as compared to Rs.540.57 crores during the 9 Months period ended December 31, 2024.


The company has posted net profit / (loss) of Rs.18.41 crores for the 9 Months period ended December 31, 2025 as against net profit / (loss) of Rs.-8.03 crores for the 9 Months period ended December 31, 2024.xxxxxxxxxxxxxxxxxxxxxxxxxxx
Cipla reports consolidated PAT of Rs. 675.80 crores
facebook sharing button Sharetwitter sharing button Tweetpinterest sharing button Pinsharethis sharing buttonwhatsapp sharing buttonemail sharing button
Posted On : 2026-01-23 21:40:08( TIMEZONE : IST )Cipla reports consolidated PAT of Rs. 675.80 croresCipla Limited has reported Consolidated financial results for the period ended December 31, 2025.
Financial Results (Q3 FY2026) - QoQ Comparison
The company has reported total income of Rs. 7280.82 crores during the period ended December 31, 2025 as compared to Rs. 7858.39 crores during the period ended September 30, 2025.
The company has posted net profit / (loss) of Rs. 675.80 crores for the period ended December 31, 2025 as against net profit / (loss) of Rs. 1351.17 crores for the period ended September 30, 2025.


The company has reported EPS of Rs. 8.36 for the period ended December 31, 2025 as compared to Rs. 16.72 for the period ended September 30, 2025.

FinancialsQ3 FY2026Q2 FY2026% ChangeTotal Income₹ 7280.82 crs₹7858.39 crsUp Tick / Down Tick-7.35%Net Profit₹675.80 crs₹1351.17 crsUp Tick / Down Tick-49.98%EPS₹8.36₹16.72Up Tick / Down Tick-50.00%
Financial Results (Q3 FY2026) - YoY Comparison
The company has reported total income of Rs. 7280.82 crores during the period ended December 31, 2025 as compared to Rs.7294.58 crores during the period ended December 31, 2024.
The company has posted net profit / (loss) of Rs.675.80 crores for the period ended December 31, 2025 as against net profit / (loss) of Rs.1570.51 crores for the period ended December 31, 2024.


The company has reported EPS of Rs.8.36 for the period ended December 31, 2025 as compared to Rs.19.43 for the period ended December 31, 2024.
FinancialsQ3 FY2026Q3 FY2025% ChangeTotal Income₹ 7280.82 crs₹7294.58 crsUp Tick / Down Tick-0.19%Net Profit₹675.80 crs₹1570.51 crsUp Tick / Down Tick-56.97%EPS₹8.36₹19.43Up Tick / Down Tick-56.97%
Financial Results (9 Months Ended FY2026) - YoY Comparison
The company has reported total income of Rs.22355.24 crores during the 9 Months period ended December 31, 2025 as compared to Rs.21390.34 crores during the 9 Months period ended December 31, 2024.


The company has posted net profit / (loss) of Rs.3324.59 crores for the 9 Months period ended December 31, 2025 as against net profit / (loss) of Rs.4050.68 crores for the 9 Months period ended December 31, 2024.xxxxxxxxxxxxxxxxxxxxxx
Laurus Labs Ltd reports consolidated net profit of Rs. 251.66 crores in Q3 FY2026
facebook sharing button Sharetwitter sharing button Tweetpinterest sharing button Pinsharethis sharing buttonwhatsapp sharing buttonemail sharing button
Posted On : 2026-01-23 22:00:43( TIMEZONE : IST )Laurus Labs Ltd reports consolidated net profit of Rs. 251.66 crores in Q3 FY2026Laurus Labs Limited has reported Consolidated financial results for the period ended December 31, 2025.
Financial Results (Q3 FY2026) - QoQ Comparison
The company has reported total income of Rs. 1784.05 crores during the period ended December 31, 2025 as compared to Rs. 1680.43 crores during the period ended September 30, 2025.
The company has posted net profit / (loss) of Rs. 251.66 crores for the period ended December 31, 2025 as against net profit / (loss) of Rs. 194.97 crores for the period ended September 30, 2025.


The company has reported EPS of Rs. 4.65 for the period ended December 31, 2025 as compared to Rs. 3.61 for the period ended September 30, 2025.

FinancialsQ3 FY2026Q2 FY2026% ChangeTotal Income₹ 1784.05 crs₹1680.43 crsUp Tick / Down Tick6.17%Net Profit₹251.66 crs₹194.97 crsUp Tick / Down Tick29.08%EPS₹4.65₹3.61Up Tick / Down Tick28.81%
Financial Results (Q3 FY2026) - YoY Comparison
The company has reported total income of Rs. 1784.05 crores during the period ended December 31, 2025 as compared to Rs.1424.47 crores during the period ended December 31, 2024.
The company has posted net profit / (loss) of Rs.251.66 crores for the period ended December 31, 2025 as against net profit / (loss) of Rs.92.30 crores for the period ended December 31, 2024.


The company has reported EPS of Rs.4.65 for the period ended December 31, 2025 as compared to Rs.1.71 for the period ended December 31, 2024.
FinancialsQ3 FY2026Q3 FY2025% ChangeTotal Income₹ 1784.05 crs₹1424.47 crsUp Tick / Down Tick25.24%Net Profit₹251.66 crs₹92.30 crsUp Tick / Down Tick172.65%EPS₹4.65₹1.71Up Tick / Down Tick171.93%
Financial Results (9 Months Ended FY2026) - YoY Comparison
The company has reported total income of Rs.5044.48 crores during the 9 Months period ended December 31, 2025 as compared to Rs.3850.19 crores during the 9 Months period ended December 31, 2024.


The company has posted net profit / (loss) of Rs.609.65 crores for the 9 Months period ended December 31, 2025 as against net profit / (loss) of Rs.124.65 crores for the 9 Months period ended December 31, 2024.xxxxxxxxxxxxxxxxxxxxxxxx
Atul Ltd posts consolidated Q3FY26 PAT of Rs. 160.74 crores
facebook sharing button Sharetwitter sharing button Tweetpinterest sharing button Pinsharethis sharing buttonwhatsapp sharing buttonemail sharing button
Posted On : 2026-01-23 21:56:51( TIMEZONE : IST )Atul Ltd posts consolidated Q3FY26 PAT of Rs. 160.74 croresAtul Limited has reported Consolidated financial results for the period ended December 31, 2025.
Financial Results (Q3 FY2026) - QoQ Comparison
The company has reported total income of Rs. 1612.21 crores during the period ended December 31, 2025 as compared to Rs. 1600.35 crores during the period ended September 30, 2025.
The company has posted net profit / (loss) of Rs. 160.74 crores for the period ended December 31, 2025 as against net profit / (loss) of Rs. 179.24 crores for the period ended September 30, 2025.


The company has reported EPS of Rs. 54.60 for the period ended December 31, 2025 as compared to Rs. 60.88 for the period ended September 30, 2025.

FinancialsQ3 FY2026Q2 FY2026% ChangeTotal Income₹1612.21 crs₹1600.35 crsUp Tick / Down Tick0.74%Net Profit₹160.74 crs₹179.24 crsUp Tick / Down Tick-10.32%EPS₹54.60₹60.88Up Tick / Down Tick-10.32%
Financial Results (Q3 FY2026) - YoY Comparison
The company has reported total income of Rs.1612.21 crores during the period ended December 31, 2025 as compared to Rs.1432.60 crores during the period ended December 31, 2024.
The company has posted net profit / (loss) of Rs.160.74 crores for the period ended December 31, 2025 as against net profit / (loss) of Rs.108.74 crores for the period ended December 31, 2024.


The company has reported EPS of Rs.54.60 for the period ended December 31, 2025 as compared to Rs.36.93 for the period ended December 31, 2024.
FinancialsQ3 FY2026Q3 FY2025% ChangeTotal Income₹1612.21 crs₹1432.60 crsUp Tick / Down Tick12.54%Net Profit₹160.74 crs₹108.74 crsUp Tick / Down Tick47.82%EPS₹54.60₹36.93Up Tick / Down Tick47.85%
Financial Results (9 Months Ended FY2026) - YoY Comparison
The company has reported total income of Rs.4716.80 crores during the 9 Months period ended December 31, 2025 as compared to Rs.4192.04 crores during the 9 Months period ended December 31, 2024.


The company has posted net profit / (loss) of Rs.467.75 crores for the 9 Months period ended December 31, 2025 as against net profit / (loss) of Rs.357.43 crores for the 9 Months period ended December 31, 2024.xxxxxxxxxxxxxxxxxxxxxxxxxx
Adani Green Energy Ltd Q3 FY26 consolidated loss at Rs. 41 crores
facebook sharing button Sharetwitter sharing button Tweetpinterest sharing button Pinsharethis sharing buttonwhatsapp sharing buttonemail sharing button
Posted On : 2026-01-23 21:50:57( TIMEZONE : IST )Adani Green Energy Ltd Q3 FY26 consolidated loss at Rs. 41 croresAdani Green Energy Limited has reported Consolidated financial results for the period ended December 31, 2025.
Financial Results (Q3 FY2026) - QoQ Comparison
The company has reported total income of Rs. 2837 crores during the period ended December 31, 2025 as compared to Rs. 3249 crores during the period ended September 30, 2025.
The company has posted net profit / (loss) of Rs. -41 crores for the period ended December 31, 2025 as against net profit / (loss) of Rs. 583 crores for the period ended September 30, 2025.


The company has reported EPS of Rs. -0.38 for the period ended December 31, 2025 as compared to Rs. 3.44 for the period ended September 30, 2025.

FinancialsQ3 FY2026Q2 FY2026% ChangeTotal Income₹ 2837 crs₹3249 crsUp Tick / Down Tick-12.68%Net Profit₹-41 crs₹583 crsUp Tick / Down Tick-107.03%EPS₹-0.38₹3.44Up Tick / Down Tick-111.05%
Financial Results (Q3 FY2026) - YoY Comparison
The company has reported total income of Rs. 2837 crores during the period ended December 31, 2025 as compared to Rs.2636 crores during the period ended December 31, 2024.
The company has posted net profit / (loss) of Rs.-41 crores for the period ended December 31, 2025 as against net profit / (loss) of Rs.492 crores for the period ended December 31, 2024.


The company has reported EPS of Rs.-0.38 for the period ended December 31, 2025 as compared to Rs.2.92 for the period ended December 31, 2024.
FinancialsQ3 FY2026Q3 FY2025% ChangeTotal Income₹ 2837 crs₹2636 crsUp Tick / Down Tick7.63%Net Profit₹-41 crs₹492 crsUp Tick / Down Tick-108.33%EPS₹-0.38₹2.92Up Tick / Down Tick-113.01%
Financial Results (9 Months Ended FY2026) - YoY Comparison
The company has reported total income of Rs.10092 crores during the 9 Months period ended December 31, 2025 as compared to Rs.9144 crores during the 9 Months period ended December 31, 2024.


The company has posted net profit / (loss) of Rs.1255 crores for the 9 Months period ended December 31, 2025 as against net profit / (loss) of Rs.1214 crores for the 9 Months period ended December 31, 2024.xxxxxxxxxxxxxxxxxxxxxxxxxxxx

Drugs Controller General ofIndia